V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007159 | 300005222 | 0 | 65.9 | Palliative (P) | null | 2013-12-12 | Trial Unspecified | 2 | null | 300019303 | CARBOPLATIN + PACLITAXEL |
| 300007160 | 300005223 | null | 66.3 | Palliative (P) | 2017-04-10 | 2017-05-26 | Cisplatin | 2 | Y | 300019440 | CETUXIMAB + RT |
| 300007161 | 300005224 | 1.7 | 73.2 | Disease modification (D) | 2016-10-04 | 2016-10-20 | CAPECITABINE + OXALIPLATIN | 02 | N | 300019952 | DOCETAXEL |
| 300007162 | 300005225 | 1.55 | null | Disease modification (D) | 2018-05-27 | 2018-06-25 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 300019981 | OXALIPLATIN + MDG |
| 300007163 | 300005226 | 1.8 | null | Palliative (P) | 2017-01-13 | 2017-01-28 | Capecitabine + Mitomycin | 02 | N | 300020166 | CISPLATIN + FLUOROURACIL |
| 300007164 | 300005227 | 1.62 | 48.5 | Not known (9) | 2015-09-24 | 2015-09-25 | Cisplatin +Fluorouracil (3 wk) | N | Y | 300020983 | CARBOPLATIN + RT |
| 300007165 | 300007176 | 1.54 | 44.6 | Palliative (P) | null | 2018-08-06 | NIVOLUMAB | N | N | 300021811 | IPILIMUMAB |
| 300007166 | 300005230 | 1.71 | null | null | null | 2017-12-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300021979 | TRIAL |
| 300007167 | 300005231 | 1.81 | 81.6 | Neo-adjuvant (N) | 2017-07-19 | 2017-08-18 | Cisplatin | N | Y | 300021979 | CETUXIMAB |
| 300007168 | 300007873 | 1.74 | 47 | Palliative (P) | 2018-04-18 | 2018-04-25 | FLUOROURACIL + OXALIPLATIN | N | N | 300022234 | CAPECITABINE + OXALIPLATIN |
| 300007169 | 300005232 | 1.71 | 68.3 | Palliative (P) | 2014-07-29 | 2014-08-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300022536 | CHOP R + LIPOSOMAL DOX |
| 300007170 | 300005233 | 1.08 | null | Palliative (P) | 2015-04-18 | 2015-05-07 | Cetuximab 7 day (>Cycle 2) | N | N | 300022663 | CAPECITABINE + OXALIPLATIN |
| 300007171 | 300005234 | 1.77 | 75.8 | Curative (C) | 2013-07-06 | 2013-07-15 | Irinotecan + Modified De Gramont | N | N | 300023961 | CAPECITABINE + OXALIPLATIN |
| 300007172 | 300005235 | null | 91.4 | Curative (C) | 2013-08-03 | 2013-08-03 | Fluorouricil + Folonic Acid (MdG) | Y | N | 300024122 | CAPECITABINE + GEMCITABINE |
| 300007173 | 300005236 | 1.64 | 90.2 | Palliative (P) | 2014-10-24 | 2014-11-23 | Oxaliplatin + Modified de Gramont | N | N | 300024122 | TRIAL |
| 300007174 | 300005240 | null | 65.7 | null | 2015-06-21 | 2015-08-14 | Cetuximab + Radiotherapy Maint | 01 | N | 300025022 | CISPLATIN + FLUOROURACIL |
| 300007175 | 300005241 | 1.74 | 65.2 | null | 2017-11-20 | 2017-11-26 | Trial Unspecified | 02 | null | 300025022 | GEMCITABINE + OXALIPLATIN |
| 300007176 | 300005242 | 1.7 | 48 | Curative (C) | 2019-05-01 | 2019-06-08 | Cetuximab 7 day (>Cycle 2) | N | Y | 300000539 | CAPECITABINE + RT |
| 300007177 | 300005243 | null | 54 | Curative (C) | 2019-04-05 | 2019-04-11 | null | 99 | null | 300003315 | TRIAL |
| 300007178 | 300005244 | 1.81 | 65 | Palliative (P) | 2017-08-03 | 2017-09-17 | Carboplatin AUC 2 - 5 | 02 | N | 300004450 | CETUXIMAB |
| 300007179 | 300005245 | 1.53 | 62 | Palliative (P) | 2018-02-28 | 2018-03-02 | Cisplatin + Fluorouracil + RT 5day | N | N | 300005566 | NAB-PACLITAXEL |
| 300007180 | 300005246 | 1.72 | 61 | Palliative (P) | 2019-06-05 | 2019-07-22 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 300006025 | CARBOPLATIN + ETOPOSIDE |
| 300007181 | 300005247 | 1.81 | 78.1 | Adjuvant (A) | null | 2018-06-09 | CISPLATIN + FLUOROURACIL | N | N | 300006118 | CAPE + CARBOPLATIN + CETUXIMAB |
| 300007182 | 300005251 | 1.64 | 39 | Adjuvant (A) | 2018-09-24 | 2018-09-24 | IMATINIB | N | N | 300008283 | TRIAL |
| 300007183 | 300005252 | 1.88 | 65 | Curative (C) | 2017-04-29 | 2017-04-30 | Capecitabine + Cisplatin + RT | 02 | Y | 300010561 | CARBOPLATIN + CETUXIMAB + FU |
| 300007184 | 300005253 | 1.59 | 68.3 | Palliative (P) | 2019-11-22 | 2019-12-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 300015101 | CVD |
| 300007185 | 300005253 | 1.61 | 83.9 | null | null | 2015-09-06 | Cetuximab + Radiotherapy Maint | null | null | 300015101 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007186 | 300005254 | 1.9 | null | Palliative (P) | 2016-08-01 | 2016-08-14 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | 300014199 | OXALIPLATIN + MDG |
| 300007187 | 300006341 | 1.78 | 88.8 | Palliative (P) | 2013-09-09 | 2017-01-16 | GEMCITABINE | N | N | 300000021 | GEMCITABINE |
| 300007188 | 300003558 | 1.6 | 47 | Curative (C) | 2017-07-25 | 2017-08-23 | Cisplatin 100 + RT(H&N) 1 day | N | N | 300000026 | CISPLATIN + RT |
| 300007189 | 300003560 | 1.6 | null | Palliative (P) | 2015-01-25 | 2015-03-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 300000085 | CISPLATIN + GEMCITABINE |
| 300007190 | 300007555 | 1.76 | 81.8 | null | null | 2016-06-08 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 300000167 | CISPLATIN + RT |
| 300007191 | 300006348 | 1.79 | 81.8 | Adjuvant (A) | 2014-05-16 | 2014-05-16 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 300000380 | GEMCITABINE |
| 300007192 | 300003570 | 1.63 | null | Palliative (P) | 2014-07-07 | 2014-07-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 300000722 | CISPLATIN + GEMCITABINE |
| 300007193 | 300003571 | 1.8 | 89.5 | Palliative (P) | 2018-01-18 | 2018-02-26 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 300000741 | CISPLATIN + GEMCITABINE |
| 300007194 | 300003575 | 1.6 | 53.1 | Adjuvant (A) | 2014-05-13 | 2014-05-27 | Cisplatin + Radiotherapy | 2 | N | 300000869 | CISPLATIN + RT |
| 300007195 | 300006354 | 1.72 | 66 | Palliative (P) | 2016-11-22 | 2016-12-30 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 300000879 | CISPLATIN + GEMCITABINE |
| 300007196 | 300003578 | 1.75 | 119.2 | Curative (C) | 2016-09-14 | 2016-09-17 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 300000888 | CISPLATIN + RT |
| 300007197 | 300003584 | 1.54 | 65.6 | Palliative (P) | 2015-06-19 | 2015-06-19 | CISPLATIN + GEMCITABINE | 02 | N | 300001250 | CISPLATIN + GEMCITABINE |
| 300007198 | 300003588 | 1.71 | 64.8 | Palliative (P) | 2019-03-18 | 2019-04-01 | CISPLATIN + GEMCITABINE | 2 | N | 300001385 | CISPLATIN + GEMCITABINE |
| 300007199 | 300003592 | null | 99 | Not known (9) | null | 2019-09-29 | CISPLATIN + RT | N | N | 300001385 | CISPLATIN + RT |
| 300007200 | 300003595 | 1.6 | 108 | Palliative (P) | 2017-04-21 | 2018-02-13 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 300001634 | CISPLATIN + GEMCITABINE |
| 300007201 | 300003596 | 1.73 | 66 | Adjuvant (A) | 2017-11-16 | 2018-01-21 | GEMCITABINE | N | N | 300001645 | GEMCITABINE |
| 300007202 | 300003598 | 1.57 | 45.3 | null | 2017-10-10 | 2017-10-15 | CISPLATIN + GEMCITABINE | 2 | Y | 300001684 | CISPLATIN + GEMCITABINE |
| 300007203 | 300003601 | 1.83 | 71.5 | Palliative (P) | 2016-05-03 | 2016-05-20 | Cisplatin+Gemcitabine (gallbladder) | 02 | null | 300001801 | CISPLATIN + GEMCITABINE |
| 300007204 | 300003602 | 1.69 | null | Palliative (P) | 2012-12-03 | 2013-11-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 300001842 | CISPLATIN + GEMCITABINE |
| 300007205 | 300003606 | null | 69.1 | Palliative (P) | 2013-10-13 | 2013-11-07 | Cisplatin+Gemcitabine (gallbladder) | N | N | 300002354 | CISPLATIN + GEMCITABINE |
| 300007206 | 300003606 | 1.7 | 70 | null | 2013-07-20 | 2013-07-22 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 300002354 | CISPLATIN + RT |
| 300007207 | 300003608 | 1.77 | 99.7 | null | 2017-12-27 | 2018-01-25 | CISPLATIN + RT | N | null | 300002442 | CISPLATIN + RT |
| 300007208 | 300003609 | 1.54 | 61.4 | Curative (C) | 2018-07-03 | 2017-12-19 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 300002520 | CISPLATIN + RT |